Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CNS Pharmaceuticals, Inc. - Common Stock
(NQ:
CNSP
)
2.510
+0.330 (+15.14%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Apr 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CNS Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
...
16
17
18
19
20
21
22
23
Next >
CNS Pharmaceuticals (NASDAQ: CNSP) to Participate at 2022 Virtual Growth Conference
March 24, 2022
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Participate at the 2022 Virtual Growth Conference
March 23, 2022
Via
Investor Brand Network
CNS Pharmaceuticals CEO Discusses Milestone In Advancing Berubicin
↗
March 18, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
CNS Pharmaceuticals (NASDAQ: CNSP) CEO Discusses Milestone in Advancing Berubicin
March 18, 2022
Via
Investor Brand Network
CNS Pharmaceuticals Marks Milestone In Pursuit Of Berubicin Approval For GBM
↗
January 26, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses Significant Milestone in Advancing Berubicin
March 17, 2022
Via
Investor Brand Network
95 Biggest Movers From Friday
↗
March 14, 2022
Gainers Marygold Companies (NYSE: MGLD) shares surged 89.4% to close at $4.11 on Friday after dropping 21% on Thursday. TeraWulf Inc. (NASDAQ: WULF) gained 49.3% to close at $9....
Via
Benzinga
CNS Pharmaceuticals Reiterates Progress For Lead Product Candidate
↗
March 10, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. CNS Pharmaceuticals (NASDAQ: CNSP),...
Via
Benzinga
CNS Pharmaceuticals (NASDAQ: CNSP) Reiterates Progress for Lead Product Candidate
March 10, 2022
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reiterates Progress for Lead Product Candidate, Addresses Recent Share Price Activity in Video to Shareholders
March 09, 2022
Via
Investor Brand Network
CNS Pharmaceuticals Gives Corporate Presentation, Q&A Session
↗
March 08, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. CNS Pharmaceuticals recently received...
Via
Benzinga
CNS Pharmaceuticals (NASDAQ: CNSP) Gives Corporate Presentation, Q&A Session
March 08, 2022
Via
Investor Brand Network
12 Health Care Stocks Moving In Monday's After-Market Session
↗
March 07, 2022
Gainers
Via
Benzinga
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Gives Corporate Presentation, Q&A Session at Virtual Investor 2022 Top Picks Conference
March 07, 2022
Via
Investor Brand Network
CNS Pharmaceuticals Announces 2021 Financial Results, Corporate Update
↗
March 04, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. CNS Pharmaceuticals (NASDAQ: CNSP), a...
Via
Benzinga
CNS Pharmaceuticals (NASDAQ: CNSP) Announces 2021 Financial Results, Corporate Update
March 04, 2022
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces 2021 Financial Results, Corporate Update
March 03, 2022
Via
Investor Brand Network
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
March 03, 2022
Good morning! In preparation for another busy day of trading, we've put together a list of the biggest pre-market stock movers for Thursday!
Via
InvestorPlace
26 Stocks Moving in Thursday's Pre-Market Session
↗
March 03, 2022
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) rose 35% to $1.06 in pre-market trading. Kiromic BioPharma, last month, reported changes in management and board of...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
February 07, 2022
Gainers Enveric Biosciences (NASDAQ:ENVB) shares increased by 12.9% to $0.7 during Monday's pre-market session. The market value of their outstanding shares is at $22....
Via
Benzinga
18 Stocks Moving in Friday's Pre-Market Session
↗
February 04, 2022
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Have a look at this: Insiders Buying Charter Communications...
Via
Benzinga
CNS Pharmaceuticals Laying Foundation For Potentially Pivotal Global Trial
↗
February 03, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
CNS Pharmaceuticals (NASDAQ: CNSP) Laying Foundation for Potentially Pivotal Global Trial
February 03, 2022
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Laying Robust Foundation for Potentially Pivotal Global Trial
February 02, 2022
Via
Investor Brand Network
Stocks That Hit 52-Week Lows On Thursday
↗
February 03, 2022
On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
January 31, 2022
Gainers Oncternal Therapeutics (NASDAQ:ONCT
Via
Benzinga
CNS Pharmaceuticals (NASDAQ: CNSP) Marks Milestone in Pursuit of Berubicin Approval for GBM
January 26, 2022
Via
Investor Brand Network
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Marks Significant Milestone in Pursuit of Berubicin Approval for Global GBM Treatment, Raises $11.5 Million from Private Placement
January 25, 2022
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's After-Market Session
↗
January 21, 2022
Gainers Mustang Bio (NASDAQ:MBIO) shares ...
Via
Benzinga
CNS Pharmaceuticals to Present at Virtual Investor 2022 Top Picks Conference
↗
January 21, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. CNS Pharmaceuticals (NASDAQ: CNSP), a...
Via
Benzinga
< Previous
1
2
...
16
17
18
19
20
21
22
23
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
